Mangompit, Bernie E.
HRN: 21-45-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2023
CEFUROXIME 750MG (VIAL)
10/10/2023
10/17/2023
IV
750mg
Every 8 Hours
Infected Skin And Muscle Secondary To Lacerated Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes